◆ 會(huì)議時(shí)間：2026年2月26-28日
◆ 會(huì)議地點(diǎn)：丹麥 哥本哈根
◆ 會(huì)議簡(jiǎn)介：
2026年第27屆歐洲婦科腫瘤學(xué)大會(huì)(ESGO2026)將于2026年2月26-28日在丹麥哥本哈根舉行，會(huì)議由歐洲婦科腫瘤學(xué)會(huì)(ESGO)主辦。歐洲婦科腫瘤學(xué)會(huì)(ESGO)年會(huì)/大會(huì)是歐洲規(guī)模最大的婦科腫瘤學(xué)會(huì)議，預(yù)計(jì)有來(lái)自世界各地的2800余名專業(yè)人士與會(huì)。ESGO大會(huì)將是一個(gè)獨(dú)特的教育體驗(yàn)，與會(huì)者將從超過(guò)70個(gè)由世界專家主持的涵蓋婦科腫瘤學(xué)主要議題的科學(xué)會(huì)議中受益，會(huì)議將使用包括全體會(huì)議、最佳口頭和海報(bào)會(huì)議等多種形式。ESGO2022將為與會(huì)者提供一個(gè)學(xué)習(xí)和討論婦科癌癥研究、治療和護(hù)理方面的最新醫(yī)學(xué)和科學(xué)進(jìn)展，以及與來(lái)自世界各地的專家和同行建立聯(lián)系的機(jī)會(huì)。
歐洲婦科腫瘤學(xué)會(huì)（ESGO）成立于1983年，是歐洲領(lǐng)先的婦科癌癥研究組織，由來(lái)自歐洲和世界各地的3400多名參與婦科癌癥治療、護(hù)理、研究的專業(yè)人員組成；ESGO致力于通過(guò)預(yù)防、卓越宣的護(hù)理，高質(zhì)量的研究和教育，提高歐洲婦科（生殖器官和乳腺）癌癥患者的健康和福祉。ESGO的愿景是：為歐洲所有婦科癌癥患者提供最佳的預(yù)防和護(hù)理（未經(jīng)許可禁止復(fù)制摘錄轉(zhuǎn)載本站任何內(nèi)容-領(lǐng)域國(guó)際醫(yī)學(xué)會(huì)議網(wǎng)(lingyuint.com)
ESGO 2026 - 27th European Congress on Gynaecological Oncology
27th Congress of the European Society of Gynaecological Oncology
Date:
February 26-28, 2026
Location:
Copenhagen, Denmark
Organized by:
European Society of Gynaecological Oncology (ESGO)
Join?ESGO 2026 Congress,
the largest European gathering in gynaecological cancers!
The?27th Congress of the European Society of Gynaecological Oncology?will bring together?over 3,000?attendees?from around the world for gathering of learning, networking, and sharing the latest developments in the field of Gynaecological Cancers —all with the goal of enhancing your knowledge, accelerating your skills and advancing the field.
ESGO 2026 will be a celebration of?discovery and late-breaking research, new guidelines,?practical demonstrations,?and exclusive?live surgery transmissions?you don't want to miss.
摘要征文投稿：
June 19, 2025
Abstract Submissions Opens
October 31, 2025
Abstract Submissions Close
*?Including late-breaking abstracts' placeholders
January 15, 2026
Late-breaking abstract submissions?Close
點(diǎn)此提交摘要>>>Submit Abstract>>>
Abstracts Topics
- Cervical cancer
- Diagnostics
- Endometrial cancer
- Fertility/Pregnancy
- Miscellaneous
- Ovarian cancer
- Palliative care
- Pathology
- Prevention of gynaecological cancer
- Quality of life after treatment
- Rare Tumours
- Translational research/biomarkers
- Trophoblastic diseases
- Vaginal and vulvar cancer
- Organization of gynaecological cancer care
- Trial in progress
- Patient advocates topic
The Scientific Programme Committee, invited faculty members, and other experts will review the abstracts after the submission deadline in?blind review. To keep transparency, please?DO NOT refer?to institution or hospital where the research took place in the body of the text.
We kindly ask you?NOT?to submit abstracts on following topics:
- Breast cancer
- Non-oncology related abstracts
- No single case reports unless accompanied by translational research or other wider research relating to the case
Instructions for Abstract Authors
- Abstracts can only be submitted via the online form, abstracts submitted by fax or email will not be accepted.
- Abstracts must be submitted in English, using UK English spelling.
- The presenting author of an accepted abstract must register and attend the congress.
- The number of submissions is limited to 3 per presenting author.
- The number of authors is limited to 20 per abstract.
- Provide a short specific title indicating the scientific content of the abstract.
The?background?and goals of the study should appear clearly to the reader. The?methods?need to outline patient group, methods applied, statistical considerations, if applicable.?Results?must contain data (except for Late Breaking abstracts [LBA]- see below), and the?conclusion?should be clearly expressed. The following structure will be required:
- Introduction/Background*
- Methodology
- Results*
- Conclusion*
- Disclosures* (online recording via the submission form)
*Mandatory fields
- The title may not exceed 30 words. PLEASE DO NOT USE CAPITAL LETTERS. The abstract text may not be longer than 300 words (excluding title, authors and disclosures).
- All abbreviations must be defined the first time they appear in the text (but do not define in the title).
- Tables, charts and other graphics (for all in total maximum 1) are permitted and must be in high resolution JPG format.
- Authors should indicate their presentation type preference:
- Oral presentation preferred
- Paper poster presentation
- E-poster only
- Video presentation
- Oral presentation in the Young investigator session (only for authors up to 40 years)
- Place holder for LBA
- The Programme committee reserves the right to decide on the final allocation and presentation method.
- Disclosure of potential?conflict of interest?(e.g., grant support, consultancy, membership on advisory councils, speaker’s bureau) by all authors and source of funding are mandatory. The submitting author is responsible for collecting a Conflict of interest form for all co-authors. All disclosures should be listed within the last 3 years. A COI template is available:?ESGO congress COI form.
- Video presentation?(abstract): Please note the abstract shall be accompanied with the video file. The file should be in .mp4 format with max. size of 500MB and maximum 5 minutes long.
- Abstracts submitted via?commercial entities?will be considered. However, these abstracts should report results from collaborative research conducted by independent (non-commercial) investigators. Investigators, as contributing authors who are employees of commercial entities will only be accepted if independent (academic, clinical and/or scientific) investigators are included as authors. The presenting author should not be an employee of the company.
- Systematic review/meta-analysis?abstracts are acceptable.
- Trials in progress (TiP)?can be accepted as posters/e-posters but will not be accepted as oral presentations. These should not previously have been presented as TiP at an ESGO congress. TiP abstracts have a separate category/topic. It is expected that abstracts submitted as TiP are ongoing trials that have not reached any protocol-specified endpoints for analysis.
- Encore abstracts?(from key data presented at 2025 international meeting as an oral presentation) can be accepted only if they have not been published; with modification and new data, if possible.? In case of a conflict of interest, please do not hesitate to contact us for clarification.
- If several abstracts are based on similar analyses of the same database and one of them is selected for oral presentation, the authors might be asked to combine some/all data into one presentation.
- Case reports?for single cases will not be accepted unless they contain substantial translational work.
- Late Breaking Abstracts (LBA)?are generally reserved for?newly emerging data?that is not available at the time of abstract submission. These could be for initial presentation of results, or significant secondary endpoint analyses. A placeholder LBA?must be?submitted containing the preliminary title, background, methods and type of results that will be presented. LBA will generally not be accepted at a later date unless a shell abstract has been submitted.
Once accepted for presentation, following information is applicable:
- Posters and/or ePosters can inlude QR codes with further information, narration or video.
- The copyright of all data belongs to authors who give permission to ESGO for publication in the IJGC and on eAcademy for registered users.
- The embargo for all abstracts end 10 days prior to the congress and on the first congress day in the case of LBA.
- The embargo for data presented orally ends at the start of the session where the data is presented.
注冊(cè)費(fèi)：
Congress Registration Fees
(in EUR, including 25% VAT)
| Registration Types |
Early-bird Rateuntil December 18, 2025 |
Standard Rateuntil February 18, 2026 |
Onsite Ratefrom February 19, 2026 |
ESGO Member?(1) |
550 € |
700 € |
950 € |
Non-member |
800 € |
950 € |
1,200 € |
Student?(3) |
125 € |
225 € |
375 € |
Resident?(2) |
175 € |
275 € |
425 € |
Fellow?(2) |
225 € |
325 € |
475 € |
Nurse?(3) |
175 € |
275 € |
425 € |
Country List A?(4) |
310 € |
410 € |
560 € |
Country List B?(4) |
160 € |
260 € |
410 € |
Industry Registration?(5) |
950 € |
1,100 € |
1,300 € |
Press Registration?(6) |
300 € |
300 € |
300 € |
(1) In order to benefit from the ESGO Membership reduced rate, membership for 2025/2026 must be valid and paid.
Please note that if you have just registered and paid for ESGO membership you will not be able to register as ESGO member for the ESGO 2026 congress immediately.
Please do not register for the congress earlier than 5 working days after paying the membership fee.
(2) Includes all physicians undergoing training in gynaecological oncology (or related specialties) in a temporary position. An official letter from the institution (PDF format) originally stamped and signed by the head of the department and confirming this status, must accompany the registration process.
(3)?An official letter from the institution (PDF format) originally stamped and signed by the head of the department and confirming this status, must accompany the registration process.
(4) Registration fees are based on country tiers as per the?World Bank classification.
Country List A?- Upper-middle-income economies
Country List B?- Low and lower-middle-income economies
(5) Industry registration - fee for company representatives (other fees are ONLY for health care professionals, clinicians, nurses).
(6) Press registration is valid for the full duration of the congress, includes a Press kit and Press release prior the congress; access to exhibition area and session halls, refreshments.?
(in EUR, including 25% VAT)
|
Mandatory Items |
|
Carbon Offset Fee |
10 € |
Practice Management Services
(to cover costs of credit card transactions?& bank transfers) |
19 € |
Optional Items |
|
Workshops?
February 25-26 & March 1, 2026 |
50 € |
ESGO Awareness Run & Walk?
February 28, 2026 |
15 € |
Networking Event
February 28, 2026? |
TBC |
Childcare
February 26-28, 2026 |
free of charge |
Registration fee includes:
- Admission to all scientific sessions (except for Workshops)
- Entrance to poster and exhibition areas
- An invitation to the welcome drink on February 26
- An invitation to farewell drink on February 28
- Coffee and lunch breaks
- Congress materials
- Access to the congress recorded sessions until June 14, 2026
◆ 參會(huì)對(duì)象：醫(yī)生、醫(yī)院科室主任/副主任、住院醫(yī)師、醫(yī)院管理者、醫(yī)護(hù)人員以及從事該領(lǐng)域研究的科學(xué)家、研究人員、醫(yī)藥企業(yè)代表等等。
|
